Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study

INTRODUCTION: Changes to Treatment and Outcomes in Patients with Type 2 Diabetes Initiating Injectable Therapy (CHOICE) is a European prospective, observational cohort study assessing time to, and factors associated with, a significant change in therapy after type 2 diabetes patients initiate their...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthaei, Stephan, Reaney, Matthew, Mathieu, Chantal, Östenson, Claes-Göran, Krarup, Thure, Guerci, Bruno, Kiljanski, Jacek, Petto, Helmut, Bruhn, David, Theodorakis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508107/
https://www.ncbi.nlm.nih.gov/pubmed/22714818
http://dx.doi.org/10.1007/s13300-012-0006-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508107/
https://www.ncbi.nlm.nih.gov/pubmed/22714818
http://dx.doi.org/10.1007/s13300-012-0006-7

Ejemplares similares